Fundraising Fox
Daniel Bradbury
InvestorFounderInvestor at BioBrit · Board director at Amplo Biotechnology · Board director at Alume Biosciences · Board director at DelNova
San Diego, California
Writes $100K – $5M checks · typically $1.5M
FoundedSensulin
Find your path to Daniel
152 people in our graph can introduce you to Daniel.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Sarah Lucas to introduce you to Daniel
Ask Alex Morgan to introduce you to Daniel
Ask Dana Petrov to introduce you to Daniel
Sign up to find every way you can get introduced to Daniel
- Your email: the people you already email who know Daniel
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Daniel
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Daniel Bradbury is the Managing Member of BioBrit, LLC. He has over 40 years of experience in life sciences executive roles, focusing on business strategy, drug commercialization, and shareholder value creation.
Board director at Amplo Biotechnology
Intro paths
→
In turn, Daniel can intro founders to Amplo Biotechnology's investors below.
Amplo Biotechnology's investors · 1
Board director at Alume Biosciences
Intro paths
→
In turn, Daniel can intro founders to Alume Biosciences's investors below.
Alume Biosciences's investors · 2
Co-founders at Alume Biosciences
QN
Quyen NguyenCo-founder
RT
Roger TsienCo-founder
Board director at DelNova
Intro paths
→
In turn, Daniel can intro founders to DelNova's investors below.
DelNova's investors · 1
Co-founders at DelNova
MG
Mary GardnerChief Executive Officer & Founder
Experience
- BioBrit, LLCManaging Membercurrent2012 — presentLa Jolla, California
- Tavo BiotherapeuticsChairman of the Boardcurrent2025 — present
- Equillium, Inc.Chairman of the Boardcurrent2025 — present
- Equillium, Inc.Executive Chairman2020 — 2025
- Equillium, Inc.Chairman of the Board and Chief Executive Officer2017 — 2019La Jolla, CA
- Alume BiosciencesExecutive Chairmancurrent2025 — present
- Alume BiosciencesDirector2020 — 2025San Diego, California, United States
- MinutiaChairman of the Boardcurrent2024 — present
- Persephone BiosciencesChairman of the Boardcurrent2023 — presentSan Diego, California, United States
- VivaniDirectorcurrent2023 — present
- Abilita Bio, Inc.Directorcurrent2022 — presentSan Diego, California, United States
- Amplo Biotechnology, IncExecutive Chairmancurrent2021 — present
- Neuralace Medical®Board Observercurrent2020 — present
- Biocon BiologicsDirectorcurrent2018 — present
- DelNovaDirectorcurrent2018 — present
- BiolinqChairman Of The Boardcurrent2017 — presentSan Diego County, California, United States
- ADCY5.orgChairman of the Boardcurrent2017 — present
- SensulinExecutive Chairmancurrent2014 — presentSan Diego County, California, United States
- Riecken Community LibrariesDirectorcurrent2013 — present
- ProSciento, Inc.Directorcurrent2013 — present
- Castle Biosciences, Inc.Chairman of the Boardcurrent2012 — presentGreater Houston
- Rady School of ManagementAdvisory Board Membercurrent2008 — presentLa Jolla, California
- Keck Graduate InstituteTrusteecurrent2006 — presentClaremont, California
- IQHQ REITDirector2019 — 2024
- Synedgen, IncDirector2019 — 2024
- SiteOne Therapeutics, Inc.Board Observer2014 — 2024
- Intercept PharmaceuticalsDirector2016 — 2023New York
- BioconDirector2013 — 2022
- AltheaDxDirector2020 — 2022
- LiquidGridsChairman of the Board2014 — 2021
- Renova TherapeuticsDirector2014 — 2021
- Panacea Acquistion CorporationDirector2020 — 2021
- DiaVacs, IncChairman of the Board2013 — 2019
- GeronDirector2012 — 2019Menlo Park
- Corcept TherapeuticsDirector2012 — 2019Menlo Park
- NeuroViaChairman Of The Board2017 — 2019San Francisco Bay Area
- MicrodermisDirector2013 — 2018
- Thesan PharmaceuticalsChairman of the Board2016 — 2017Carlsbad, California
- IlluminaDirector2004 — 2017San Diego
- Freedom Meditech Inc.Chairman of the Board2014 — 2017San Diego County, California, United States
Skills & more
Oncology48Technology Transfer45Clinical Development99Drug Discovery65Biotechnology74Diabetes55Clinical Trials49CEO Succession5Cross-functional Team Leadership33Lifesciences3Data Management4Drug Development99
+12 more
GCPSopChange ControlMedical DevicesBiopharmaceuticalsProduct LaunchMedical WritingPharmacologyPharmaceutical IndustryCROClinical Research21 CFR Part 11From Daniel's professional profile.
Investments
Per curated public sources.
Frequently asked questions
- Who is Daniel Bradbury?
- Daniel Bradbury is the Managing Member of BioBrit, LLC. He has over 40 years of experience in life sciences executive roles, focusing on business strategy, drug commercialization, and shareholder value creation.
- Where does Daniel Bradbury work?
- Daniel Bradbury is Executive Chairman and Co-Founder of Sensulin and Investor at BioBrit and Board director at Amplo Biotechnology and Board director at Alume Biosciences and Board director at DelNova.
- What check size does Daniel Bradbury write?
- Daniel Bradbury typically writes checks of $100K – $5M.
- What companies did Daniel Bradbury found?
- Daniel Bradbury founded Sensulin.
- What companies has Daniel Bradbury invested in?
- Investments tracked here include Alume Biosciences, Amplo Biotechnology.
- Where did Daniel Bradbury go to school?
- Daniel Bradbury studied at University of Nottingham (Bachelor of Pharmacy (B.Pharm.), Pharmacy); UCLA Anderson School of Management (Director Certification Program, Corporate Governance); INSEAD (AMP).
Founder mafias
INSEAD mafia398
Also came through, then founded or led a company.
UCLA Anderson School of Management mafia128
Also came through, then founded or led a company.
University of Nottingham mafia73
Also came through, then founded or led a company.
University of West London mafia7
Also came through, then founded or led a company.
Intercept Pharmaceuticals mafia6
Also came through, then founded or led a company.
Paul SekhriBoard DirectorFounded VtvtherapeuticsRachel McMinnChief Business and Strategy OfficerFounded NeurogeneSenthil SundaramHead of Business/Corporate DevelopmentFounded Terns PharmaceuticalsAlex MartinCOOFounded AbcuroMike YoungConsultant, Organizational Development & PlanningFounded Comanche Biopharma
Same school
Also attended UCLA Anderson School of Management417
David Clark GuillermoInvestments at Impact America FundDana MoralyPartner; Chief Financial & Administrative Officer at March Capital PartnersJed LeidheiserPartner at March Capital PartnersShahin FarshchiPartner at Lux CapitalMonica PlazaOperating Partner at CapitalGJennifer SavagePartner at Illuminate Ventures
+ 411 more
Also attended INSEAD1,330
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
+ 1,324 more
Also attended University of West London15
Marwan SafiLP Relations at Transform Capital ManagementHarrison WardTeam Coordinator at Sagard Credit PartnersOlivia LythInvestor at Sustainable VenturesJosephine Awatefe-SaroukInvestor at Rising Tide Africa (RTA)Silva KartaliyskaFinance & Business Operations Manager at Cherry VenturesJames StothardHead of Investor Engagement at Oxford
+ 9 more
Shared employers
Also worked at Tavo Biotherapeutics2
Also worked at Neuralace Medical®1
Also worked at Rady School of Management9
Garnet HeramanFounder and Managing Partner at Aperture Venture CapitalEthan ChangFounder at Forge RewardsDennis WhiteExecutive Officer, Director at CytodymeOzge Islegen-Wojdyla, Ph.D.Founder at true-meterMarianna ZipetoEVP, Growth, Strategy & Enablement at Champions OncologyJason (Zhen) QiFounder at CB Therapeutics
+ 3 more
Also worked at Intercept Pharmaceuticals13
Paolo FundaròFounder and Managing Partner at XGEN VenturePaul SekhriInvestor at eGenesis, Inc. Full-timeKlaus VeitingerVenture Partner at OrbiMedLisa DeFrancescoExecutive Officer at Lexicon PharmaceuticalsRachel McMinnExecutive Officer, Director at Neurogene IncSenthil SundaramDirector, Executive Officer at Terns Pharmaceuticals
+ 7 more